Levobupivacaine Hydrochloride Patent Expiration

Levobupivacaine Hydrochloride is used for local anesthesia and pain management. It was first introduced by Purdue Pharma Lp in its drug Chirocaine on Aug 5, 1999.


Levobupivacaine Hydrochloride Patents

Given below is the list of patents protecting Levobupivacaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Chirocaine US5708011 Use of levobupivacaine in a patient having depressed myocardial contractility Oct 13, 2014

(Expired)

Purdue Pharma Lp



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List